Last reviewed · How we verify
Nonradiographic axial spondyloarthritis
Approved treatments
- Simponi · Centocor Ortho Biotech Inc
Simponi works by binding to tumor necrosis factor, preventing it from interacting with its receptors and thereby reducing inflammation. - Enbrel · Immunex
Enbrel works by binding to tumor necrosis factor, a protein that promotes inflammation, thereby reducing inflammation and alleviating symptoms. - Simponi · Alvotech Swiss AG
- Enbrel · LG Life Sciences
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nonradiographic axial spondyloarthritis patent landscape — cliff calendar, originator estates, attackable patents
- Nonradiographic axial spondyloarthritis treatment landscape brief
- Nonradiographic axial spondyloarthritis treatment updates RSS
Frequently asked questions about Nonradiographic axial spondyloarthritis
What drugs treat Nonradiographic axial spondyloarthritis?
Tracked treatments include Simponi, Enbrel.
What is the treatment for Nonradiographic axial spondyloarthritis?
Standard treatment for Nonradiographic axial spondyloarthritis includes Simponi, Enbrel. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nonradiographic axial spondyloarthritis patent cliff · Nonradiographic axial spondyloarthritis CI report
- Treatment: Simponi · Centocor Ortho Biotech Inc
- Treatment: Enbrel · Immunex
- Treatment: Simponi · Alvotech Swiss AG
- Treatment: Enbrel · LG Life Sciences
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing